Cecilia Williams
Principal Researcher
E-mail: cecilia.williams@ki.se
Visiting address: Blickag氓ngen 16, 14152 Flemingsberg
Postal address: H7 Medicin, Huddinge, H7 GUT Williams, 171 77 Stockholm
About me
- Hormone signalling and non-coding RNAs in cancer
Cecilia Williams leads a group at KI that is shared with her lab at KTH and SciLifeLab. She received her PhD training in DNA sequencing technologies and the p53 tumor suppressor gene at KTH, postdoc training in gene expression profiling techniques and stem cells, and was later a researcher at 探花精选 where she studied the role of estrogen receptor beta. In 2009, she joined the Center of Nuclear Receptors and Cell Signaling at University of Houston as Assistant Professor and received a tenured Associate Professorship in 2015. Her main activities at BioNut are focused at understanding hormonal signalling and the role of non-coding RNAs in cancer, and include supervision of doctoral students.
Education
1994 M.S. (Civ. Ing.) in Chemical Engineering with specialization in Biotechnology, KTH Royal Institute of Technology, Stockholm
2002 Ph.D. Biotechnology, KTH Royal Institute of Technology. /Molecular Archaeology of Cancer - Analysis of the Human p53 Tumor Suppressor Gene.
Research
- Hormone signalling and non-coding RNAs in cancer
The Williams鈥 group focuses on understanding key molecular mechanisms in cancer, applying a combination of large-scale genomic approaches, focused mechanistic experiments and animal studies. The goal is to understand critical pathways so that we can define biomarkers of their activity and suggest better cancer treatments and preventive approaches. The hormone estrogen increases the risk of breast cancer, but can simultaneously protect against colorectal cancer. It is not understood exactly how, but if we can achieve a detailed knowledge of this mechanism, we could design approaches that can protect against colon cancer while not promoting breast cancer.
Estrogenic signaling is mediated by the estrogen receptors, ERalpha, ERbeta and GPER1. ERalpha and ERbeta are ligand-activated nuclear receptors and as such excellent therapeutic targets. Our research focuses on understanding estrogen-induced pathways in breast and colon cancer, and the impact that environmental or dietary estrogenic exposure may have. Related to this, is the identification of molecular mechanisms involving microRNAs and long non-coding RNAs, molecules with great potential as novel biomarkers and therapeutic targets. These molecules are likely to contribute to the estrogenic effects, but this area remains to be explored. Our previous work include identification of the estrogen-regulated transcriptome, the roles of specific microRNAs in cell migration, and expression and regulations of lncRNAs, with a focus on cancer.
Teaching
Course responsible, teacher, and examiner for Clinical Applications of Biotechnology (6.0 credits, 2019-2023), Master's programme in Molecular Techniques in
Life Science (SciLifeLab)
Articles
- Article: CANCER LETTERS. 2025;622:217661
- Article: JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY. 2024;242:106526
- Article: ENVIRONMENT INTERNATIONAL. 2024;190:108937
- Article: MOLECULAR SYSTEMS BIOLOGY. 2024;20(4):374-402
- Article: TOXICOLOGICAL SCIENCES. 2023;193(2):119-130
- Article: PROTEIN & CELL. 2023;14(2):123-136
- Article: INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH. 2023;20(5):4181
- Article: SCIENCE OF THE TOTAL ENVIRONMENT. 2023;858(Pt 3):160023
- Article: CANCERS. 2022;14(24):6029
- Article: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2022;23(18):10408
- Journal article: ANNALS OF ONCOLOGY. 2022;33:s640
- Article: CANCERS. 2022;14(13):3098
- Article: CANCERS. 2022;14(6):1414
- Article: METHODS IN MOLECULAR BIOLOGY. 2022;2418:313-343
- Article: METHODS IN MOLECULAR BIOLOGY. 2022;2418:203-221
- Article: METHODS IN MOLECULAR BIOLOGY. 2022;2418:1-23
- Article: CELL BIOLOGY AND TRANSLATIONAL MEDICINE, VOL 14: STEM CELLS IN LINEAGE SPECIFIC DIFFERENTIATION AND DISEASE. 2022;1390:213-225
- Article: FRONTIERS IN ENDOCRINOLOGY. 2022;13:930227
- Article: ACTA ONCOLOGICA. 2021;60(7):881-887
- Article: ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2021;53(11):1216-1225
- Article: CANCER LETTERS. 2021;506:23-34
- Article: SCIENCE OF THE TOTAL ENVIRONMENT. 2021;755(Pt 1):142939
- Article: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2021;22(3):1354
- Article: FRONTIERS IN ENDOCRINOLOGY. 2021;12:650625
- Article: CANCER LETTERS. 2020;492:54-62
- Article: SCIENTIFIC REPORTS. 2020;10(1):16160
- Article: PEERJ. 2020;8:e9434
- Article: MABS. 2020;12(1):1794421
- Article: CANCER MEDICINE. 2019;8(18):7705-7719
- Article: JOURNAL OF CELLULAR PHYSIOLOGY. 2019;234(12):22220-22233
- Article: BMC CANCER. 2019;19(1):684
- Article: INTERNATIONAL JOURNAL OF CANCER. 2019;144(12):3086-3098
- Article: METHODS IN MOLECULAR BIOLOGY. 2019;1966:79-99
- Journal article: CELL SYSTEMS. 2018;7(4):422-437.e7
- Article: ONCOTARGET. 2018;9(28):19730-19744
- Journal article: CANCER RESEARCH. 2017;77:4401
- Journal article: CANCER RESEARCH. 2017;77:2819
- Article: CANCER LETTERS. 2017;396:42-52
- Article: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2017;109(3):1-14
- Article: PLOS ONE. 2017;12(2):e0172832
- Article: ONCOTARGET. 2016;7(27):42159-42171
- Article: INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. 2016;57(6):2689-2698
- Article: ONCOGENE. 2016;35(15):1955-1964
- Article: METHODS IN MOLECULAR BIOLOGY. 2016;1366:373-393
- Article: MOLECULAR ENDOCRINOLOGY. 2015;29(11):1634-1645
- Article: CARCINOGENESIS. 2015;36(9):1051-1060
- Article: PLOS ONE. 2015;10(5):e0128239
- Article: MOLECULAR ONCOLOGY. 2014;8(8):1690-1702
- Article: FASEB JOURNAL. 2014;28(10):4247-4264
- Article: ONCOGENE. 2014;33(34):4340-4351
- Article: CANCER RESEARCH. 2014;74(14):3983-3994
- Article: ENDOCRINE-RELATED CANCER. 2014;21(2):143-160
- Article: TOXICOLOGICAL SCIENCES. 2014;138(1):21-35
- Article: JOVE-JOURNAL OF VISUALIZED EXPERIMENTS. 2014;(84):e51285
- Article: ENDOCR DISRUPTORS (AUSTIN). 2014;2(1):e29088
- Article: TOXICOLOGICAL SCIENCES. 2013;135(1):91-102
- Article: CARCINOGENESIS. 2013;34(7):1431-1441
- Article: BREAST CANCER RESEARCH. 2013;15(3):R51
- Article: MOLECULAR ENDOCRINOLOGY. 2012;26(12):1991-2003
- Article: CARCINOGENESIS. 2012;33(9):1684-1691
- Article: CARCINOGENESIS. 2012;33(8):1502-1511
- Journal article: CANCER RESEARCH. 2012;72(8_Supplement):547
- Article: JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY. 2012;128(3-5):145-153
- Article: PLOS ONE. 2012;7(3):e32080
- Journal article: CANCER RESEARCH. 2011;71(24_Supplement):p1-02-04-p1-02-04
- Article: MOLECULAR ENDOCRINOLOGY. 2011;25(8):1326-1336
- Article: MOLECULAR ENDOCRINOLOGY. 2011;25(6):969-979
- Journal article: CANCER RESEARCH. 2011;71(8_Supplement):271
- Journal article: CANCER RESEARCH. 2009;69(24_Supplement):1162
- Article: CANCER RESEARCH. 2009;69(15):6100-6106
- Article: BREAST CANCER RESEARCH. 2009;11(3):R26
- Article: ONCOGENE. 2008;27(7):1019-1032
- Article: BMC DEVELOPMENTAL BIOLOGY. 2007;7:129
- Article: EXPERIMENTAL CELL RESEARCH. 2006;312(10):1798-1812
- Article: BMC GENOMICS. 2006;7:75
- Article: PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE. 2002;18(6):287-293
- Article: ONCOGENE. 2001;20(53):7770-7778
- Article: ANALYTICAL BIOCHEMISTRY. 2000;287(1):25-31
- Article: AMERICAN JOURNAL OF PATHOLOGY. 1999;155(5):1467-1471
- Article: GENE. 1999;235(1-2):103-109
- Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 1999;8(5):433-438
- Article: ONCOGENE. 1998;17(14):1837-1843
- Article: GENOMICS. 1998;50(2):213-221
- Article: CANCER RESEARCH. 1998;58(11):2449-2455
- Journal article: JOURNAL OF DERMATOLOGICAL SCIENCE. 1998;16:s48
- Journal article: JOURNAL OF DERMATOLOGICAL SCIENCE. 1998;16:s145
- Article: CLINICAL CHEMISTRY. 1998;44(3):455-462
- Article: MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS. 1997;382(1-2):45-55
- Article: ONCOGENE. 1997;15(9):1059-1067
- Article: AMERICAN JOURNAL OF PATHOLOGY. 1997;150(5):1791-1803
- Journal article: MELANOMA RESEARCH. 1996;6(SUPPLEMENT 1):s53
- Article: CLINICAL CHEMISTRY. 1995;41(10):1461-1466
- Show more